{
  "name" : "_cyber.sci-hub.se_MTAuMTAzOS9jNW5yMDc0Mzdh_wang2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Self-assembled nanomaterials for photoacoustic imaging",
    "authors" : [ "Lei Wang", "Pei-Pei Yang", "Xiao-Xiao Zhao", "Hao Wang" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication.\nAccepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available.\nYou can find more information about Accepted Manuscripts in the Information for Authors.\nPlease note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.\nAccepted Manuscript\nNanoscale\nwww.rsc.org/nanoscale\nView Article Online View Journal\nThis article can be cited before page numbers have been issued, to do this please use: H. Wang, L. Wang,\nP. Yang and X. Zhao, Nanoscale, 2015, DOI: 10.1039/C5NR07437A."
    }, {
      "heading" : "Nanoscale",
      "text" : "REVIEW\nThis journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1\nPlease do not adjust margins\nPlease do not adjust margins\nReceived 00th January 20xx, Accepted 00th January 20xx\nDOI: 10.1039/x0xx00000x\nwww.rsc.org/\nSelf-assembled nanomaterials for photoacoustic imaging\nLei Wang,* Pei-Pei Yang, Xiao-Xiao Zhao and Hao Wang*\nIn recent years, extensive endeavors have been paid to the construction of functional self-assembled nanomaterials for various applications, such as catalysis, separation, energy and biomedicine etc. So far, different strategies have been developed for preparation of nanomaterials with diversified structures and functionalities via fine tune of self-assembled building blocks. In term of biomedical applications, bioimaging technologies are urgently called for high-efficient probes/contrast agents for high-performance bioimaging. Photoacoustic (PA) imaging is an emerging whole-body imaging modality offering high spatial resolution, deep penetration and high contrast in vivo. The self-assembled nanomaterials show high stability in vivo, specifically tolerance to sterilization and prolonged half-life stability and desirable targeting properties, which are a kind of promising PA contrast agents for biomedical imaging. Herein, we focus on summarizing recent advances in smart self-assembled nanomaterials with NIR absorption as PA contrast agents for biomedical imaging. According to the preparation strategy of contrast agents, we categorize the self-assembled nanomaterials into two groups, i.e., the ex situ and in situ self-assembled nanomaterials. The driving forces, assembly modes and regulation of PA properties of self-assembled nanomaterials and their applications for long-term imaging, enzyme activity detection and aggregation-induced retention (AIR) effect for diagnosis and therapy are emphasized. Finally, we conclude with an outlook towards future developments of self-assembled nanomaterials for PA imaging."
    }, {
      "heading" : "1. Introduction",
      "text" : "Supramolecular chemistry was originated and inspired by biological phenomena, i.e. recognition and self-assembly, the generality and fundamental significance of which was endowed by Lehn and Cram. 1 Supramolecular nanoassemblies by molecular modules through non-covalent interactions, including hydrogen bonds, π-π, hydrophobic interactions and etc., play an important role in nature, which have attracted wide attentions from chemists, biologists and material scientists. 2-10 So far, various nanoassemblies from different building blocks have been prepared in organic and aqueous solutions with defined superstructures and multi-functionalities for biomedical imaging 11-15 and disease diagnostics 16-20 . Recently, in situ construction of self-assembled nanomaterials in living systems has become a new challenge, which could be achieved in vitro and in vivo with sophisticated responsiveness to accomplish diagnosis and/or therapy of diseases. 21-35\nPA effect was discovered by Alexander Graham Bell at 1880. 36, 37 The PA effect refers to the phenomenon wherein matter absorbs a short-pulsed laser beam and converts its energy into sound (via heat, which induces localized pressure changes). 38-43 However, the real application of this technique had to wait almost a century until the development of the laser in the 1960s which provided the high peak power, spectral purity and directionality that many PA sensing\napplications require. It was not until the mid-1990s that the PA effect was initially investigated for biomedical imaging and the field grew rapidly with development of instrumentation, image reconstruction algorithms and in vivo application of the technique in clinical medicine and basic biological research. Wang et al. used PA microscopy based PA imaging system to achieve functional and structural imaging in vivo in 2003. 44 They commercialized the PA imaging system (Endra Nexus 128), which have been widely used for fundamental biomedical researches. 45 The Razansky and Ntziachristos et al. used multispectral optoacoustic tomography (MSOT), which is another commercial available PA imaging system, to image the mouse heart in 2012. 46, 47 PA imaging combines high spatial resolution of ultrasonic imaging and high contrast of optical imaging. Compared with other biomedical imaging platform (Table 1), the PA imaging system (MSOT as a representative example) can be effectively complementary of others and has its own advantages. 48, 49 For example, the PA imaging based on MOST showed high sensitivity compared with ultrasound (US), Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) techniques. Meanwhile, the spatial resolution of the PA imaging is higher than Positron Emission Tomography (PET), Optical and Single-Photon Emission Computed Tomography (SPECT) imaging modalities. Furthermore, PA imaging can perform high throughput and real-time imaging. However, as it is shown in Table 1, the sensitivity and penetration depth need to be further improved. With the development of the PA instrumental set-up, the design and preparation of new PA contrast agents are desirable to enhance the imaging performance including the imaging contrast, resolution and depth of detection.\nPage 1 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\nTable 1. PA imaging system (MSOT) performance versus other imaging modalities. 47\nSelf-assembled nanomaterials, as a kind of promising PA contrast agents with pre-organized structure and functionality, can show better photo/chemical stability, and prolonged half-life stability compared with small molecular contrast agents. 50, 51 Furthermore, the desirable targeting can be easily imparted with surface modification or assembly to self-assembled nanomaterials. 52, 53 Moreover, the self-assembled PA contrast agent with two PA materials can synergistically enhance the performance of PA imaging. Together with the enhanced permeability and retention (EPR) effect, the nanomaterial PA contrast agents usually show high sensitivity and high specificity. Recently, Prof. G. Zheng reviewed a supramolecular nanosystem based on porphyrin-lipid (porphysome) and the application for PA imaging. 4 In this review, we summarize this rapidly growing field of self-assembled nanomaterials as PA contrast agents for biomedical imaging. More importantly, the in situ organized nanomaterials in living systems has been reviewed side-by-side with ex situ organized nanomaterials. The ex situ organized nanomaterials are divided into nanoparticles, nanovesicles and nanomicelles based on the supramolecular structures (Figure 1). Meanwhile, the in situ assemblies are summarized according to the assembly strategy. Finally, we discuss the future challenges in the field of self-assembled nanomaterials of PA imaging.\nFigure 1. Different classes of self-assembled nanomaterials for PA imaging.\n2. Ex situ assembly"
    }, {
      "heading" : "Nanoparticles",
      "text" : "Organic dyes with maximum absorption in the NIR range can be used for PA imaging. Generally, the organic dyes absorb NIR light and convert the photo-energy into heat via non-radiative relaxation pathways such as molecular vibrations. 54 As a result, the NIR dyes with low fluorescence quantum yield (lower ratio of photons emitted to photons absorbed, more of the absorbed energy can be converted into heat) preferred to generate strong PA signals. The organic dyes, e.g. cyanine, 55, 56 porphyrin 43, 57-59 and borondipyrromethene (BODIPY 60, 61 , Figure 2) derivatives and so on have been explored by many research groups as PA contrast agents. However, the stability and uncontrolled aggregation of organic dyes have limited their application in PA imaging. The supramolecular approach could be utilized to overcome these drawbacks by loading organic dyes into nanocarriers.\nThe organic dyes can be post-loaded into hydrophobic domain of amphiphilic polymer nanoparticles through hydrophobic interactions. 62 For example, Yoon et al. embedded ICG in a novel polymer-protein hybrid nanocarrier (Figure 3a). 55 This nanocarrier was synthesized through human serum albumin (HSA) and amine functionalized monomer, followed by polymerization in a water-inoil emulsion. The ICG dye was loaded into the HSA conjugated polyacrylamide (PAA) nanoparticles (HSA-PAA NPs) through postloading. The presence of hydrophobic pockets in the HSA-PAA NPs\nincreased the chemical and physical stability of ICG. The diameter of the dehydrated (3% ICG)-HSA-PAA NPs was around 48 nm (Figure 3b). The UV-vis absorption spectrum of ICG-HSA-PAA NPs with strong PA signal showed two strong peaks at 720 and 790 nm. Similarly, Kohl and his co-workers introduced multifunctional nanoparticles loaded with NIR dyes (IR-5/IR-26). 63 The nanoparticles showed excellent PA contrast properties as promising candidates for a resorbable PA contrast system. The self-assembled nanoparticles could be obtained from small molecules without involving amphiphilic polymers as nanocarriers, too. Liu et al. prepared nanoassemblies of J-aggregates based on a NIR dye as a PA imaging-guided drug carrier for enhanced cancer therapy. 64 The IR825 was complexed with a low-molecular-weight cationic polymer polyethylenimine (PEI) in water to form IR825@PEI J-aggregates with greatly enhanced NIR absorbance red-shifted to 915 nm. The self-assembled J-type nanoaggregates were further modified with polyethylene glycol (IR825@PEI-PEG nano-complex), which exhibited great dispersity in physiological solutions, excellent photostability, and was able to efficiently load chemotherapeutic drug doxorubicin (DOX). The PA imaging from IR825 indicated high tumor uptake of the IR825@PEI-PEG nano-complex in vivo upon intravenous injection. The combined photothermal & chemotherapy in vivo demonstrate great synergistic anti-tumor therapeutic effect remarkably superior to those achieved by the respective mono-therapies.\nFigure 2. The molecular structures of organic dyes with NIR absorbance used in nanomaterials.\nFigure 3. (a) The structure illumination and (b) TEM imaging of 3% ICG loaded-HSA-PAA NPs. (Reproduced with permission. 55 Copyright 2013, Royal Society of Chemistry)\nFigure 4. (a) Molecular structures of SP1 and SP2 used for the preparation of SPN1 and SPN2, respectively. (b) PA/ultrasound co-registered images of the nanoparticle-matrigel inclusions in mice at a concentration of 8 μg mL -1 . The images represent transverse slices through the subcutaneous inclusions (dotted circles). (c) Proposed ROS sensing mechanism. (d) PA images of macrophage RAW264.7 cell pellets (1.5× 10 6 cells) without (top) or with (middle) stimulation with LPS/INF-g, and with NAC protection (bottom). Cell pellets were inserted into an agar phantom and imaged with a pulsed laser tuned to (i) 700 nm or (ii) 820 nm. (iii) Overlays of images from (i) and (ii). (e) Quantification of the absorption ratio (PA700/PA820) for macrophage cell pellets with and without LPS/INF-g or LPS/INF-g/NAC treatment. (Reproduced with permission. 65 Copyright 2014, Nature)\nThe hydrophobic polymer dyes with NIR absorption could selfassemble followed by surfactant stabilization or co-assemble into nanoparticles with surfactant in water. For example, Rao and his coworkers developed a new class of PA contrast agents with NIR light absorption based on semiconducting polymer nanoparticles (SPNs) for PA molecular imaging (Figure 4a). 65, 66 A THF solution of semiconducting polymers (1 mL) was rapidly injected into distilled deionized water (9 mL) under continuous sonication with a microtip-equipped probe sonicator. Then, 1,2-dipalmitoyl-snglycero-3-phosphocholine (DPPC) in THF/water was added into the mixture. THF was evaporated at 45 °C under nitrogen atmosphere\nPage 2 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3\nPlease do not adjust margins\nPlease do not adjust margins\nto obtain the nanoprecipitation of SPNs.The SPN1 showed stronger absorption than SPN2 at 700 nm, resulting in much higher PA signals of SPN1 than that of SPN2. Both nanoparticles can generate stronger signals than the commonly used single-walled carbon nanotubes and gold nanorods on a per mass basis (Figure 4b). The SPNs possessed high structural flexibility and strong resistance to photodegradation and oxidation. Furthermore, by coupling SPNs to a cyanine dye derivative (IR775S) that was sensitive to ROSmediated oxidation, they demonstrated the NIR ratiometric PA probe (RSPN) for in vivo real-time imaging of reactive oxygen species (ROS) (Figure 4c). The PA spectrum of RSPN showed three maxima at 700, 735 and 820 nm. In the presence of ONOO - and ClO - , the PA peak from IR775S dyes almost disappeared, but the peak at 700 nm from SPN1 remained nearly the same. However, other ROS could not affect the PA spectrum. The detection of endogenously generated ROS by RSPN was tested in cultured murine macrophage cells. In normal condition (cells in the resting state), RSPN showed strong PA signals at both 700 and 820 nm (Figure 4d), resulting in PA700/PA820 = 1.4+0.43 (Figure 4e). In the mimic inflammatory condition that stimulates resting macrophages to produce ROS, the PA signal at 820 nm was nearly disappeared (Figure 4d), leading to an enhanced PA700/PA820 of 7.3+0.96 (Figure 4e). When the ROS was scavenged by N-acetylcysteine (NAC), PA700/PA820 returned to a low value (3.3+0.78). An overlay of pseudocoloured PA images (Figure 4d) could represent ROS levels in cells. Polypyrrole (PPy) as PA contrast agents was reported by Dai and his co-workers in 2013. 67 They prepared PPy nanoparticles by aqueous phase polymerization using PVA as the stabilizing agent and FeCl3 as an oxidation catalyst (Figure 5a, b). The PPy nanoparticles were well dispersed in water with strong absorption in the 700-900 nm regions. Intravenous administration of PPy nanoparticles allowed imaging of the cerebral cortex of the mouse brain vasculature with greater clarity than the intrinsic signal from hemoglobin in blood. At 1 h post-injection, the PA signals remained essentially intense, indicating that a sufficient amount of PPy nanoparticles has longcirculating ability in blood. 67, 68 Liu also reported the conjugated polymer, which showed strong NIR absorbance for PA imaging. 69, 70 They prepared nanoparticles of NIR polymer (poly[9,9-bis(4-(2ethylhexyl)phenyl)fluorene-alt-co-6,7-bis(4-(hexyloxy)phenyl)-4,9di(thiophen-2-yl)-thiadiazoloquinoxaline, PFTTQ, Figure 5c), which were co-assembled with DSPE-PEG by precipitation method in water (Figure 5d). As a result of strong absorbance and high nonradioactive quantum yield, PFTTQ based nanoparticles showed a strong ability to generate a PA signal. In addition, PFTTQ nanoparticles showed much higher photostability in comparison with Au NRs upon high energy pulse laser illumination.\nFigure 5. (a) Chemical structures of PPy. (b) Schematic illustration of the formation of PPy NPs in an aqueous dispersion of water-soluble polymer– metal cation complexes. (c) Chemical structures of the PFTTQ polymer. (d) Schematic illustration of the fabrication of PFTTQ NPs using DSPE-PEG2000 for stabilization through a precipitation method. (a, b: Reproduced with permission. 67 Copyright 2013, Royal Society of Chemistry; c-d: Reproduced with permission. 70 Copyright 2014, Royal Society of Chemistry)\nCarbon nanomaterials, such as graphene oxide (GO) and singlewalled carbon nanotubes (SWNT) exhibit many unique intrinsic\nproperties due to large π-conjugation. NIR dyes, generally πconjugated molecules, can be loaded onto the carbon nanomaterials through π-π interactions. Different from the above polymer nanocarriers, the carbon nanomaterials themselves have NIR absorption and PA effect. The carbon nanomaterials can enhance the PA signals of organic dyes by quenching the fluorescence through π-π interactions, showing synergistic PA effect. Zerda et al. presented a family of novel PA contrast agents that were based on the binding of organic dyes to SWNTs (dyeSWNT). 71, 72 They prepared five different dye-SWNT hybrid nanoparticles as contrast agents using different organic dyes. The dyes was dissolved in DMSO first and then added to PEGylayed SWNT water solutions with a final DMSO concentration of <10% by volume overnight. Unbound dye molecules were removed from the solution by filtration through 100 kDa centrifuge filters and washed 6-8 times. Furthermore, the cyclic RGD peptides were conjugated with SWNT, which are molecularly target the αvβ3 integrins (Figure 6a). The supramolecuar nanocomposite of QSY and ICG dyes with SWNT showed strong optical absorption (Figure 6b), which could be ascribed to proper π-π interactions, leading to sub-nanomolar sensitivities. These tumor-targeted imaging agents in tumor-bearing mice by intravenous administration showed significantly higher PA signal in the tumor than that in mice injected with the SWNT-RGD contrast agent (Figure 6c). More importantly, the PA signals of QSYSWNT and ICG-SWNT can be spectrally separated in living animals injected subcutaneously with both particles in the same location, opening the possibility for multiplexing in vivo studies.\nQin, Yang and Xing reported the design of a PA nanoprobe with the highest availability of optical-thermo conversion by using GO and dyes via π-π stacking interactions. 73 The GO-dye nanoprobes were prepared by adding dyes into phosphate buffer saline (PBS) of GO. After stirring for 2 h, the unattached dyes were removed by being centrifuged at 13000 rpm for 10 min. The GO served as a base material for loading dyes and quenching dye fluorescence via fluorescence resonance energy transfer (FRET) (Figure 7a). Experiments verified that the designed fluorescence quenching nanomaterials could produce stronger PA signals than the sum of the separate signals generated in the dye and the GO (Figure 7b, c). The fluorescence quenching nanomaterials as contrast agents were demonstrated to image the deep-seated tissues and tumors in living mice by enhancing PA contrast. PA therapy efficiency both in vitro and in vivo by using the fluorescence quenching nanoprobes was found to be higher than with the commonly used PA contrast agents. The study demonstrated that quenching dye fluorescence via FRET would provide a valid means for developing high-efficiency PA nanoprobes. Similarly, Li and Yang combined ICG with GO to obtain enhanced PA signals utilizing the π-π stacking interactions between GO and ICG, 74 which had a high absorbance in the NIR region and exhibited excellent photothermal and PA properties under NIR irradiation.\nPage 3 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\naggregates of cells. (a, b: Reproduced with permission. 71 Copyright 2012, American Chemical Society; c: Reproduced with permission. 72 Copyright 2010, American Chemical Society)\nFigure 7. (a) π–π stacking of dyes in close proximity to GO. GO quenches the dye fluorescence via FRET between dye molecules and GO. Using the pulse laser irradiation, the vast majority of absorbed light energy is converted to acoustic waves. The comparison of PA imaging contrast of tumors after being injected with GO–Abs/Cy7, GO–Abs, and Cy7. U87-bearing Balb/c nude mice (n = 3) was injected through the tail vein withGO–Abs/Cy7 (b), and separate GO-Abs and Cy7 solutions were injected simultaneously into the same mice (c). The white dotted lines on the images illustrate the approximate tumor edges. (Reproduced with permission. 73 Copyright 2015, Wiley Publishing Group)\nThe proteins, as biological materials, have been widely used for\nthe delivery of imaging and therapeutic agents. 75 The plantinfecting brome mosaic virus (BMV) acted as a nanocarrier, where the genomic content was eliminated and was replaced with ICG. 76 The capsid protein (CP) subunits of BMV remained as the encapsulating shell to form the resembling nano-constructs (optical viral ghosts, OVGs). ICG was added to purified suspension of CP subunits, and the mixture was then dialyzed against reassembly buffer at 4 °C for 24 h. Encapsulation of ICG by CP subunits is a selfassembly process mainly governed by electrostatic interaction between negatively charged ICG molecules and positively charged CP subunits. These nano-constructs could provide higher PA signals than blood in tissue phantoms and displayed superior photostability compared to nonencapsulated ICG without an acute immunogenic response in healthy mice. An et al. reported the Albumin and NIR squaraine dye (SQ-1) nanoassemblies for PA imaging in vivo. 77 The SQ-1 dye was loaded and aggregated in albumin, which induced a NIR absorption at around 800 nm from the visible-light region. Thus, the PA signal could be generated in the tissue-transparent NIR optical window (700-900 nm). Blood analysis and histology measurements revealed that the nanocomplex could be used for PA tomography applications in vivo without obvious toxicity to living mice.\nThe perfluorocarbon (PFC) nanoparticles show great potential for biomedical imaging and drug delivery applications, which are stabilized with single phospholipid layer. The dyes can be loaded the hydrophobic layer of the PFC/phospholipid nanoparticles, where the hydrophobic domain are relative confined and the optical properties can be controlled more easily than that of the nanoparticles carrier. Akers et al. 60 found that the fluorescence quenching occurred in the formulation of NIR fluorescent dyes in nanoparticles resulted in enhanced contrast for PA imaging (Figure 8a). They developed a nanocarrier with PFC as a core and amphiphilic phospholipid as a shell, which loaded the two kinds of NIR dyes into the hydrophobic domain. The nanoparticles were composed of perfluorooctylbromide (PFOB) and a surfactant comixture (including 98 mol % lecithin) in distilled water. The PPCyC8 dyes were substituted for lecithin on an equimolar basis. By controlling the quantity and ratio of PPCy-C8 dye in the nanocarrier, both optical and PA contrast were tuned. The results showed the benefit of nanomaterials for the enhancement of contrast by increasing the payload per particle. The PA and fluorescence\ndetection system allowed quantitative detection of regional lymph nodes of rats with time-domain optical and PA imaging methods in vivo (Figure 8b). Zheng also reported microbubbles (MBs) as bimodal or trimodal imaging agents (ultrasound, PA, and fluorescence) with the shell of phospholipid monolayer, which was co-assembled with amphiphilic porphyrin derivative molecules (Figure 8c). 59 The trimodula MBs showed strong PA spectrum from the NIR absorption of porphyrin. The trimodal porphyrin shell (porshe) MBs showed detectable increase in PA signal after injection (Figure 8d).\nFigure 8. (a) Schematic of dye-loaded PFC nanoparticles. The PFC core is encapsulated in an amphiphilic phospholipid layer (blue) containing hydrophobic dyes (green). (b) Bright-field and PA images of ex vivo lymph nodes 24 h after intradermal administration of PPCy-C8/PFC nanoparticles into the left forepaw of the rat. (c) Schematic of trimodal MBs. (d) In vivo imaging of MBs in a KB tumor xenograft at 10-30 s post intravenous injection of 280 μL of MB-PBS solution at a concentration of 2 × 10 9 MBs/mL. (a, b: Reproduced with permission. 60 Copyright 2011, American Chemical Society); c, d: Reproduced with permission. 59 Copyright 2014, American Chemical Society)"
    }, {
      "heading" : "Nanovesicles",
      "text" : "The NIR dyes can be loaded into the hydrophobic layer of the nanovesicles, which is formed by phospholipid bilayer. The hydrophobic domain of the nanovesicles is relative confined and the optical properties can be controlled more easily than that of the nanoparticle carriers. Wang and Frank prepared NIR absorbing and emission squaraine (SQ) dyes, which had good stability and high photo resistance. They modulated the aggregation of SQ dyes in hydrophobic phospholipid bilayers of nanovesicles with variable mixing ratios of the SQ dye and the nanovesicles, to achieve dual NIR fluorescence and PA tomography dual-modular imaging (Figure 9). 78 The L-α-phosphatidylcholine and cholesterol (4:1 w:w) were dissolved in the ethanol solution. Afterward, the SQ containing DMSO solution was added into the mixed ethanol solution. The resulting mixture was subsequently injected into PBS and kept stirring for 1 h. The SQ molecules preferentially embedded into hydrophobic phospholipid bilayer of liposome through hydrophobic interactions. The SQ dye loaded nanovesicles were 76±15 nm in size (Figure 10a), which was in accordance with the dynamic light scattering (DLS) result (Size: 103±14 nm, PDI: 0.18). When doping minimal amounts of SQ (1:500), molecularly dispersed SQ in bilayers showed remarkable fluorescence (Figure 10b). Interestingly, the PA signals were enhanced with the increase of SQ in the nanoconfined bilayer region, which were due to the formation of SQ-based H-aggregates and enhanced thermal conversion efficiency (Figure 10c). NIR fluorescence imaging in vivo indicated that the majority of SQ ⊂ L were enriched in the area where the blood vessels were generated, implying that the liposomal nanocarriers exhibited lower tumor tissue penetration capability after the vascular leakage (Figure 10d). The research indicated that the importance of supramolecular modulation (monomer or aggregation) of NIR dyes loaded in the nanomatrix, which would determine the characteristics and application of the dye-doped nanomaterials.\nPage 4 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5\nPlease do not adjust margins\nPlease do not adjust margins\nFigure 9. Schematic diagram of the nanoconfined SQ assemblies in phospholipid bilayer and the utilization of these vesicles as probes for dual modular tumor imaging in vivo. (Reproduced with permission. 78 Copyright 2014, American Chemical Society)\nFigure 10. (a) TEM images of SQ ⊂ L. (b) UV-vis absorption spectra and the corresponding fluorescence intensity changes (inset, λex: 680 nm) of aggregated SQ (4 μM) in PBS and SQ monomers (4 μM) in SQ ⊂ L. (c) PA signal was enhanced with increasing ratio of SQ and phospholipid in liposomes from 1:500 to 1:10 (w/w). (d) PA imaging of tumor in MCF-7 xenografted mice: (I) and (II) are the representative photos of tumor bearing mice with different treatments; (III) and (IV) show one transverse slice in the 3D PA image of tumor bearing mice with treatment of liposome and SQ ⊂ L. The dashed line and the white dashed circle indicate the skin and outlines of tumor site of mice, respectively; (V) and (VI) show the aligned images from the different transverse section of control and treated groups. 78 Copyright 2014, American Chemical Society)\nTo further increase the controllability of self-assembly, the organic dyes are modified into amphiphilic molecules and act as building blocks to form NIR absorbing nanovesicles by themselves. Porphyrin, a NIR absorbance and hydrophobic molecules, was modified through an acylation reaction between lysophosphatidylcholine and pyropheophorbide by Zheng and his co-workers (Figure 11a). 57-59 This hydrophobic porphyrin was positioned in place of an alkyl side chain and the amphiphilic porphyrin derivative could form porphyrin bilayers through selfassembly (Figure 11a, b). Porphysomes were formed by dispersion and evaporation of lipids and porphyrin-lipids to form a film. Films were rehydrated with PBS, subjected to freeze-thaw cycles and extruded with a 100 nm polycarbonate membrane at 65 °C. The highly ordered packing of prophyrin quenched the fluorescence, increased the absorption and corresponding PA intensity. As a result, the PA intensity was higher than the clinically used contrast agent methylene blue. Meanwhile, the PA signal could attenuate on detergent-induced porphysome dissociation (Figure 11c). The porphysomes enabled the sensitive visualization of lymphatic systems using PA tomography (Figure 11d). As a nanomaterial, porphysomes accumulated in tumors of xenograft-bearing mice could induce photothermal tumor ablation under laser irradiation. As a result of their organic nature, porphysomes were enzymatically biodegradable and induced minimal acute toxicity in mice (Figure 11a). The optical properties and biocompatibility of porphysomes demonstrated the multimodal potential of organic nanovesicles for biomedical imaging and therapy.\nFigure 11 (a) The molecular structure and schematic representation of a pyropheophorbide-lipid porphysomes and enzymatic degradation of the porphysomes. The phospholipid headgroup (red) and porphyrin (blue) are highlighted in the subunit. (b) TEM of porphysomes (5% PEG–lipid, 95% pyropheophorbide–lipid). (c) PA images of tubing containing porphysomes and PBS measured 0.5% Triton X-100. (d) The PA lymphatic mapping. Rats were imaged using PA tomography before and after intradermal injection of porphysomes (2.3 pmol). Secondary lymph vessels (cyan), lymph node (red), inflowing lymph vessel (yellow) and 5 mm scale bar are indicated. (Reproduced with permission. 57 Copyright 2011, Nature)\nThe cyanine dyes are generally difficult to self-assemble in water due to coulombic repulsion from the nitrenium ion. Wang and his co-workers introduced a bis-pyrene unit with strong hydrophobicity and large π-conjugation to the cyanine molecule by etherification reaction (Figure 12a). 79 The synthesized BP-Cy could self-assemble into a well-organized nanovesicles by solvent-switch method. The BP-Cy (weight of 0.2 mg) was dissolved in DMSO (10 μL), and then deionized water (2 mL) was slowly injected into the above solution for several days. The prepared nanovesicles could absorb NIR light with super chemical and photostability. This is the first time that the cyanine dyes form vesicular nanoassemblies without templates (Figure 12b, c). Interestingly, compared with the monomer and analogue ICG molecules, the stable nanovesicles showed significantly improved PA signal intensity and half-life in vitro and in vivo (Figure 12d-f). The study demonstrated that supramolecular strategy could effectively improve the photostability of organic dyes.\nFigure 12. (a) Molecular structures of BP-Cy. (b) TEM images of BP-Cy vesicles with negative staining. The expansions indicate the thickness of the bilayer membrane and the diameter of the vesicle in each case. (c) Schematic space-filling model for the vesicle. (d) PA imaging In vivo model mice injected with ICG and BP-Cy aggregate (2.0 × 10− 5 M, 200 μL) via tail vein and detected under laser irradiation (790 nm) The quantification of normalized PA signals from the tumor injected with ICG (blue line) and BPCy aggregate (red line) for different time intervals and corresponding PA images of tumors. (f) The PA images were reconstructed by ImageJ. (Reproduced with permission. 79 Copyright 2015, Royal Society of Chemistry)\nThe noble metal, especially gold nanoparticles (GNPs) have been brought to the forefront of cancer research in recent years because of their facile synthesis and surface modification. Furthermore, the surface plasmon resonance (SPR), a unique phenomenon to plasmonic GNPs leads to strong electromagnetic fields on the particle surface and consequently enhances all the radiative properties such as absorption and scattering with 5-6 orders of magnitude stronger than most strongly absorbing organic dye molecules. 80 Hence, the GNPs can efficiently convert optical energy into heat and can be utilized as potential contrast agents for PA imaging. However, the large nanoparticles tend to show slow excretion from the body, which limits their biomedical application.\nRecent studies indicated that the hierarchical assembly of small GNPs allows one to engineer the localized surface plasmon resonance (LSPR) peaks to the NIR region owing to plasmon coupling between adjacent Au NPs for enhanced photothermal treatment (PTT) and PA imaging with improved clearance after the dissociation of assemblies. Thus, the GNPs dramatically increase the possibility for clinical application with originally superior photothermal conversion efficacy compared with organic NIR dyes. For example, Chen et. al. reported the biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for PA imaging and PTT. They prepared a novel theranostic platform based on biodegradable plasmonic gold nanovesicles for PTT and PA imaging (Figure 13a). 81 The poly (ethylene glycol)-b-poly(εcaprolactone) (PEG-b-PC) block-co-polymer (BCP) graft with a disulfide bond at its terminus allowed dense packing of GNPs\nPage 5 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\n(Figure 13b) with specific interparticle orientations during the process and induced an ultra-strong plasmonic coupling effect between adjacent GNPs. Figure 13c showed the representative SEM images of well-defined vesicular assemblies of GNPs. The plasmon coupling induced the strong NIR absorption, resulting in high efficient PTT and high performance PA imaging (Figure 13d, e). Furthermore, the multifunctional GNPs showed high solubility and stability in aqueous media, thus facilitating their biomedical application. It is most important that the self-assembled gold nanovesicles could be biodegradable to release small GNPs with improved clearance. Similarly, they developed a multifunctional theranostic platform by loading photosensitizer chlorine e6 (Ce6) into gold vesicular assemblies of GNPs for effective cancer imaging and treatment. 82 The as-prepared gold vesicles composed of a monolayer of assembled GNPs showed strong absorbance in the NIR range. Together with the encapsulating photosensitizer Ce6, the golden nanovesicles enabled trimodality NIR fluorescence/thermal/PAI and synergistic photothermal & photodynamic therapy (PTT/PDT) with improved efficacy.\nFigure 13. Self-assembled and biodegradable gold vesicles (BGVs) with an ultrastrong plasmonic coupling effect are superior PA imaging and PTT agents with improved clearance after the dissociation of the assemblies. The PA signal and PTT efficiency of BGVs are increased as the distance (d) between adjacent GNPs decreases. (b) Self-assembly of BGVs composed of poly(ethylene glycol)-b-poly(ε-caprolactone) (PEG-b-PCL)-tethered GNPs through the dot-line-plane-vesicle mode during the dialysis process. (c) SEM images of GV (top left), BGV1 (top right), BGV2 (bottom left), and BGV3 particles (bottom right). (d) UV-Vis-NIR spectra of GNPs, PEG-b-PS-tethered gold vesicles (GVs), and block-copolymer-tethered biodegradable gold vesicles produced by the dialysis of solutions of GNPs (100, 150, and 250 mg mL -1 ) in THF. The LSPR peaks of the BGVs can be tuned by varying the GNP concentration. (e) PA signals of BGVs and GNRs as a function of optical density. (Reproduced with permission. 81 Copyright 2013, Wiley-VCH)"
    }, {
      "heading" : "Nanomicelles",
      "text" : "The hydrophobic organic dyes with NIR absorption self-assemble into nanomicelles as PA contrast agent for PA imaging. Cai and his co-workers reported a family of nanomicelles that can avoid systemic absorption and provide good optical contrast for PA imaging (Figure 14a). 83 The naphthalocyanine dyes (Figure 14b) was dissolved in 1 mL dichloromethane and added to an F127 solution. The naphthalocyanine was co-assembled with F127 into nanomicelles with the size of ~20 nm due to strong hydrophobicity (Figure 14c). Interestingly, Due to the temperature-sensitive CMC, the free F127 could be removed without destroying the frozen micelle structures at 4 °C. The frozen nanomicelles (nanoraps) showed tunable and large near-infrared absorption intensity. Moreover, the nanonaps exhibited high stability and passed safely through the gastrointestinal tract. Hence, the nanoraps could be utilized to observe the two US/PA maximum intensity projections (MIPs) by tracing the movement of nanonaps through the intestine over a 30 minute period (Figure 14d). The indicated regions of interest showed, in real time, the out-of-plane passing of nanonaps through a transverse slice of the intestine. Compared to control regions B and C, which contained relatively constant nanoparticles\nvolumes, nanonaps quantitatively exited from region A over one minute and demonstrated peristaltic contractions in the process. Non-invasive, non-ionizing PA techniques were used to visualize nanonap intestinal distribution with low background and remarkable resolution, and enabled real-time intestinal functional imaging with ultrasound co-registration. Zhao et al. reported the NIR squaraine dye (SQ-2) encapsulated micelles for in vivo fluorescence and PA bimodal imaging. 84 SQ-2 was encapsulated inside micelles constructed from F-127 to obtain SQ-2-encapsulated micelles in aqueous conditions. The micelle encapsulation retained both the photophysical features and chemical stability of SQ-2. The SQ-2 micelle exhibited high photostability and low cytotoxicity in biological conditions. Unique properties of SQ-2 micelle in the NIR window of 800-900 nm enabled the development of a squarainebased exogenous contrast agent for fluorescence and PA bimodal imaging above 820 nm. SQ-2 micelle, as demonstrated by fluorescence and PA tomography experiments in live mice, showed contrast-enhanced deep tissue imaging capability in vivo. The usage of SQ-2 micelle proven by preclinical experiments in rodents revealed its excellent applicability for NIR fluorescence and PA bimodal imaging. Liu and his co-workers engineered multifunctional nanomicelles for combined photothermal and photodynamic therapy under the guidance of multimodal imaging. 56 The multifunctional polymeric nanomicelle system containing a photosensitizer Ce6 was successfully fabricated, together with a NIR dye, IR825. The theranostic micelles could be utilized as a contrast agent for fluorescence and PA imaging of tumors in a mouse model. The combined photothermal and photodynamic therapy was carried out, achieving a synergistic anti-tumor effect both in vitro and in vivo.\nFigure 14. (a) Generation of purified nanonaps. F127 PEO blocks are in blue, PPO blocks in black and Nc dyes in red. (b) Chemical structure of napthalocyanines used. ONc: M=2H; R1=H; R2, R3=O-(CH2)3CH3. (c) Negativestained TEM of dried nanonaps. Scale bar, 50 nm. (d) US (grey)/PA (color) MIPs of transverse slices, showing ONc nanonap intestinal transit over time. The MIP was used to orient the PA signal within a single slice of interest (lower left). Outflow quantification over time of nanonaps in area A (red) shown with reference to two others that maintained steady nanonap content in areas B (blue) and C (grey). The fluctuations in A are due to contractile inflow and outflow of nanonaps. (Reproduced with permission. 60 Copyright 2014, Nature).\n3. In situ assembly\nAs mentioned above, the pre-organized nanoassemblies have been developed as PA contrast agent for the biomedical fields. The structure and surface composition of the self-assembled nanomaterials can be controlled in well-defined chemical conditions. However, the physiochemical parameters of resulting nanoassemblies as well as designed biological functions will compromise due to the unexpected complicated bio-environments. An alternative strategy, in situ construction of nanomaterials in biological conditions with signal transmutation to execute diagnostics and/or therapeutics, is developed recently. 21-32, 85-89 Xu and his coworkers founded supramolecular hydrogelation inside living cells in situ, triggered by enzyme with increasing the\nPage 6 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7\nPlease do not adjust margins\nPlease do not adjust margins\nfluorescence signals due to the hydrophobic effect. 21-23 Rao and Liang reported a condensation reaction-induced hydrophobicity increase, resulting in aggregation to form nanostructures. The condensation reaction can be controlled by reduction or enzyme under physiological conditions with fluorescence, photoacoustic, magnetic resonance or radioactive readout. 24-29 Tang and Liu introduced aggregation-induced emission (AIE) effect-based supramolecular aggregation in living cells to monitor cell apoptosis, where the AIE molecules were released from their conjunction with peptide by caspase-3. 30-32 The in situ self-assembly is generally realized from the small molecule with hydrophobic aggregatable units and hydrophilic responsive groups (prevent the aggregation due to hydrophicility and steric hindrance). 21-32 The hydrophobic aggregatable units self-assemble when the hydrophilic group left upon physiological condition stimuli. Meanwhile, Wang et al. reported supramolecular approach to realize the in situ formation of nanoassemblies in living cells, which involved the pH-responsive amphiphilic carrier and aggregatable monomer bis-pyrene. 90 The nanocarrier delivered the bis-pyrene to the lysosomes of cells. In the acidic lysosomes, the bis-pyrene monomers were released and self-aggregated with turn-on fluorescence. Overall, the formation of nanoassemblies should bring the signal enchantment upon stimuli to realize specific diagnosis/therapy functionality.\nFigure 15. Schematic illustration of activatable oligomerization-induced construction of nanoassemblies in situ for PA imaging of furin-like activity in vivo. (Reproduced with permission. 91 Copyright 2012, American Chemical Society)"
    }, {
      "heading" : "Internal stimuli-responsive assembly",
      "text" : "It is possible to construct nanomaterials as PA contrast agent in situ because the NIR dyes could quench the fluorescence and enhance intensity of PA signals when aggregation. For example, Rao and his coworkers introduced in situ condensation reaction and selfaggregation induced by enzyme, which provided PA contrast to report the enzyme activity in living subjects (Figure 15). 91 The molecular precursor includes furin responsive peptide as a cage group, condensation reaction group and NIR dyes. In furin overexpressing region, the molecular precursor was activated to accomplish the condensation reaction followed by the in situ aggregation to form nanoassemblies. Thus, the probe provided furin and furin-like activity in cells and tumor models by generating a significantly higher PA signal relative to furin-deficient and nontarget controls. This activatable PA probe could report enzyme activity in living subjects at depths significantly greater than fluorescence imaging probes.\nFigure 16. Schematic illustration of the structure of compound 1 and it responsively self-assembled into nanofibers in tumor sites that exhibited AIR effect for improving PA imaging signal and tumor therapeutic efficacy. (Reproduced with permission. 92 Copyright 2015, Wiley Publishing Group)\nFigure 17. (a) In situ quantification of PA signal intensity in tumor site with time increase from 0.5 to 24 h post-injection. (b) TEM image (inset) of nanofibers formed in tumor site at 10 h-post intravenous injection of compound 1 and the corresponding the energy-dispersive profiles acquired\nat the region of interests (ROIs) indicated by red stars. (c) The schematic illustration of the AIR effect of compound 1 in tumor site compared with compound 2 which was quickly excreted from the tumor. (Reproduced with permission. 92 Copyright 2015, Wiley Publishing Group)\nWang and etc. rationally designed a responsive small-molecule precursor (1) that self-assembled into nanofibers in tumor sites exhibiting assembly-induced retention (AIR) effect, and improved PA imaging signal and enhanced therapeutic efficacy (Figure 16). 92 The compound 1 was composed of purpurin 18 (P18) as the functional molecule, Pro-Leu-Gly-Val-Arg-Gly (PLGVRG) as the enzyme-responsive peptide linker, and Arg-Gly-Asp (RGD) as the targeting ligand. Initially, hydrophilic small molecule 1 in physiological environment readily diffused, extravasated and targeted to αvβ3 integrins that overexpressed on U87 cancer cell membranes. Then, gelatinase, which was over-expressed in tumor microenvironment, selectively cut the PLGVRG linker. The residue of 1 with enhanced the hydrophobicity and reduced less steric hindrance self-assembled into nanofibers. Finally, the selfassembled fibrous nanostructures exhibited prolonged retention time in tumors that directly led to an enhanced PA signal and therapeutic efficacy. The AIR effect in tumor site was evaluated in the αvβ3 integrin and gelatinase-overexpressed U87 cells xenografted mouse model. The mice were intravenously injected with 1 (the responsive building block, P18-PLGVRGRGD), 2 (P18PMGMRGRGD without responsiveness), 3 (P18-PLGVRGRDG without targeting) or PBS and PA imaging of tumor was carried out on a MOST. As shown in Figure 17a, the PA signal of 1 and 3 in tumor sites enhanced in 2 h after injection, reached a maximum at 6 h, and kept a strong PA signal till to 24 h (Figure 17a), which was induced by the AIR effect of responsive building blocks. The PA signal of tumor treated by 1 was nearly two times higher than that of 3, indicating contribution of the targeting group to the enhanced PA signal. The quantification of average tumor PA signals (Figure 17a) of tumors treated with 1 was 16-fold higher than that of 2 at 8 h postinjection. More importantly, the long-time retention in tumor site with half retention time. (τ1/2) of compound 1 was nearly to 24 h due to the in situ assembly, which was six-fold longer than that of 2 (4 h). As a result of AIR effect, the photothermal treatment effect was enhanced due to the accumulation of 1 residues compared with control molecule 2. In addition, based on UV/vis spectra of the extraction from the tumor after 4 d injection of 1, they can deduce that the 1 was hydrolysed, which was further confirmed by MALDITOF-MS. The hydrolysed product is a hydrophilic molecule that resulted in disassembly of assembly and excreted out of the solid tumor (Figure 17c). To clearly visualize and confirm in situ formation of the nanofibers of 1 from the tissue background, they labeled the P18 motif with zinc(II) ions to increase the contrast of samples. The fibrous structures of self-assembly of compound 1 were observed in tumor tissues by TEM (Figure 17b) and further checked by energydispersive spectrometry (EDS). The AIR effect based on the assembly of supramolecular structures in living systems will pave the way to develop novel functional nanomaterials for cancer diagnostics and therapeutics.\nBy using the similar strategy, they realized specific and sensitive photoacoustic imaging of bacterial infection in vivo (Figure 18a). 93 They designed and synthesized the building block (Ppa-PLGVRG-Van\nPage 7 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "8 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\n1), which is composed of pyropheophorbide-α (Ppa) as a signaling molecule, Pro-Leu-Gly-Val-Arg-Gly (PLGVRG) as an enzymeresponsive peptide linker, and vancomycin (Van) as a targeting ligand. The Ppa-PLGVRG-Van is selectively cleaved by gelatinase to form hydrophobic building blocks which readily self-aggregate in vitro and in vivo. They developed a tissue-mimicking phantoms infected with various species of bacteria to confirm the in situ aggregation. The aggregation-induced enhancement of the photoacoustic signal was explained by the increased heat conversion efficiency of aggregates compared to monomers, which was predicted by theory and confirmed experimentally. In vivo, the specific accumulation and aggregation of Ppa-PLGVRG-Van in the microenvironment created by bacterial infection leads to a significant amplification of the PA signal in situ, which was used to detect bacterial infections in a highly sensitive and specific way (Figure 18b). The in situ responsive nanomaterials as PA contrast agent in living systems will provide new possibilities for biomedical applications such as tissue engineering, biosensing, bioimaging and gene/drug delivery. Wang and his co-workers also prepared pH responsive nanocarrier micelle-like nanoparticles which could encapsulate the hydrophobic drug for cancer therapy. To monitor the drug release profile, they loaded the SQ molecule into the nanocarrier as hydrophobic modular molecule to construct an activatable PA probe, which could be released in acidic condition and self-aggregated with enhanced PA signals. 94 Finally, they elevate the drug release profile of the pH nanocarrier in the lysosome of living cells by PA imaging of SQ nanoassemblies.\nFigure 18. (a) Illustration of bacterial infection imaging based on an in vivo aggregation strategy. Firstly, the targeting molecule (Van) causes PpaPLGVRG-Van to accumulate at the site of responsive bacterial myositis; then, the gelatinase produced by gelatinase-positive bacteria in the infectious microenvironment cleaves the peptide linker, triggering self-aggregation in situ; finally, the supramolecular aggregates significantly enhance the photoacoustic signal so that the bacterial infection can be detected by imaging. (b) PA images and PA signal intensity distribution in transverse sections of mice up to 72 h after injection with 1. (Reproduced with permission. 93 Copyright 2015, Wiley Publishing Group)"
    }, {
      "heading" : "External stimuli-responsive assembly",
      "text" : "Converting monomeric compounds into supramolecular nanostructures by endogenous or external stimuli is increasingly popular because these materials are useful for imaging and treating diseases. 85, 86 At the same time, supramolecular nanostructures can also be converted from microstructures. Zheng et al. showed the in situ conversion of microbubbles to nanoparticles using lowfrequency ultrasound (Figure 19). 95 The microbubble consists of a bacteriochlorophyll–lipid shell around a perfluoropropane gas (Figure 20a). The encapsulated gas provided ultrasound imaging contrast and the porphyrins in the shell conferred PA and fluorescent properties. Upon exposure to ultrasound, the microbubbles bursted and formed smaller nanoparticles (Figure 20b, c) that possessed the same optical properties as the original microbubbles. The conversion was possible realized in tumorbearing mice upon ultrasound, where the PA signals kept for longer time (120 min) compared with that (2 min) of the tumor-bearing\nmice without ultrasound stimuli (Figure 20d). The results indicated that the in situ construction of nanoassemblies could effectively deliver drugs to tumors or long term PA imaging with enhanced permeability and retention (EPR) effect.\nFigure 19. Schematics of porphyrin microbubbles (pMBs) and their micro-tonano conversion. (a) Molecular structure of BChl-lipid. (b) Self-assembled pMBs consist of a BChl-lipid shell encapsulating perfluorocarbon gas. (c) Porphyrin nanoparticles (pNPs) converted from pMBs via sonication with low-frequency, high-duty-cycle ultrasound (conversion ultrasound). (Reproduced with permission. 95 Copyright 2015, Nature)\nFigure 20. (a) Light microscopy image of pMBs. (b) TEM image of pNPs formed from pMBs after ten ultrasound pulses. (c) TEM image of liposomelike structures formed from pNPs after placing pNPs in a vacuum. (d) Normalized PA signal over time in the tumor, with conversion ultrasound not applied (blue) or applied (green). PA values are normalized to the peak PA value. Mean ± 1 s.d. (n = 3). Only in tumors in which conversion ultrasound was applied does the pNP remain at the tumors site, indicating successful delivery to the tumor. (Reproduced with permission. 95 Copyright 2015, Nature)"
    }, {
      "heading" : "4. Conclusion",
      "text" : "The aforementioned results show the self-assembled nanomaterials from structures to their applications in PA biomedical imaging. Supramolecular nanoassemblies as contrast agents, have many advantages compare to small molecules, such as high stability, specific targeting property and EPR effect, which further result in high sensitivity and specificity. However, the preparation reliability of self-assembled nanomaterials is a key issue, which is due to the difficulty in controlling the supramolecular interactions. At the same time, it is possible to transform the morphologies, structures, and corresponding PA properties in the complicated physiological condition in vivo, ascribed to the dynamic nature of self-assembled nanomaterials. For all the nanomaterials, the biodistribution, toxicological and safety issues in vivo should be evaluated before clinical diagnostics and therapeutics of diseases.\nFor ex situ self-assembled nanomaterials, the much effort should be given to well-controlled preparation with definite parameters such as size, shape, charge, payload, surface chemistry and stability. Especially, the PA properties (excitation wavelength and ultrasound intensity) of supramolecular nanoassemblies as PA contrast agents should be precisely tuned by adjusting the aggregation modes of organic dyes. Furthermore, the different PA contrast materials could be cooperated with each other and be optimized to obtain high sensitive and specific PA contrast agents by self-assembly, which could meet the requirement of high performance PA contrast agents for clinical application.\nOn the other hand, the in situ self-assembly is much more interesting field that draws great attention from fundamental research. The in situ self-assembly can be intelligent to monitor the biological process, activity of biomolecules and disease diagnosis in vivo. Furthermore, the in situ assembly showed long retention time, which was called aggregation-induced retention (AIR) effect, resulting in high performance of imaging and treatment. The design\nPage 8 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 9\nPlease do not adjust margins\nPlease do not adjust margins\nof sophisticated precursor for self-assembly would be a large challenge for the in situ assembly with PA signal difference.\nFor all the self-assembled nanomaterials, the biodistribution, such as liver and spleen, and their toxicity in vivo following systemic administration need to be evaluated through standardized, validated methods. Furthermore, the morphology and structure transformation followed by the disassembly and excretion of selfassembled nanomaterials in vivo should be paid great effort. The self-assembled nanomaterials with disassembility and degradability with high biocompatibility and low toxicity by systematically evaluation could be applied to clinical diagnostics and therapeutics of diseases. By collaboration with the multidisciplinary researchers from chemistry, biology and medicine, we believe that the selfassembled nanomaterials will lead to benefits to all of us in the future."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was supported by National Natural Science Foundation of China (51473188, 21374026, 21304023, and 51303036), National Basic Research Program of China (973 Program, 2013CB932701), Program of Beijing Municipal Science and Technology (Z141100000214008) and the 100-Talent Program of the Chinese Academy of Science (Y2462911ZX)."
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "10 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\n59. E. Huynh, C. S. Jin, B. C. Wilson and G. Zheng, Bioconjugate Chem., 2014,\n25, 796-801.\n60. W. J. Akers, C. Kim, M. Berezin, K. Guo, R. Fuhrhop, G. M. Lanza, G. M.\nFischer, E. Daltrozzo, A. Zumbusch, X. Cai, L. V. Wang and S. Achilefu, ACS Nano, 2011, 5, 173-182. 61. M. Frenette, M. Hatamimoslehabadi, S. Bellinger-Buckley, S. Laoui, J. La,\nS. Bag, S. Mallidi, T. Hasan, B. Bouma, C. Yeleswarapu and J. Rochford, J. Am. Chem. Soc., 2014, 136, 15853-15856.\n62. K. Li and B. Liu, Chem. Soc. Rev., 2014, 43, 6570-6597. 63. Y. Kohl, C. Kaiser, W. Bost, F. Stracke, M. Fournelle, C. Wischke, H.\nThielecke, A. Lendlein, K. Kratz and R. Lemor, Nanomedicine, 2011, 7, 228-237. 64. X. Song, R. Zhang, C. Liang, Q. Chen, H. Gong and Z. Liu, Biomaterials,\n2015, 57, 84-92.\n65. K. Pu, A. J. Shuhendler, J. V. Jokerst, J. Mei, S. S. Gambhir, Z. Bao and J.\nRao, Nat. Nanotech., 2014, 9, 233-239.\n66. K. Pu, J. Mei, J. V. Jokerst, G. Hong, A. L. Antaris, N. Chattopadhyay, A. J.\nShuhendler, T. Kurosawa, Y. Zhou, S. S. Gambhir, Z. Bao and J. Rao, Adv. Mater., 2015, 10.1002/adma.201502285. 67. Z. Zha, Z. Deng, Y. Li, C. Li, J. Wang, S. Wang, E. Qu and Z. Dai, Nanoscale,\n2013, 5, 4462-4467.\n68. X. Song, H. Gong, S. Yin, L. Cheng, C. Wang, Z. Li, Y. Li, X. Wang, G. Liu and\nZ. Liu, Adv. Funct. Mater., 2014, 24, 1194-1201.\n69. G. Balasundaram, C. J. H. Ho, K. Li, W. Driessen, U. S. Dinish, C. L. Wong,\nV. Ntziachristos, B. Liu and M. Olivo, Int. J. Nanomedicine, 2015, 10, 387- 397. 70. J. Liu, J. Geng, L.-D. Liao, N. Thakor, X. Gao and B. Liu, Poly. Chem., 2014,\n5, 2854-2862.\n71. A. de la Zerda, S. Bodapati, R. Teed, S. n. Y. May, S. M. Tabakman, Z. Liu,\nB. T. Khuri-Yakub, X. Chen, H. Dai and S. S. Gambhir, ACS Nano, 2012, 6, 4694-4701. 72. A. d. l. Zerda, Z. Liu, S. Bodapati, R. Teed, S. Vaithilingam, B. T. Khuri-\nYakub, X. Chen, H. Dai and S. S. Gambhir, Nano Lett., 2010, 10, 2168- 2172.\n73. H. Qin, T. Zhou, S. Yang and D. Xing, Small, 2015, 11, 2675-2686. 74. Y. Wang, Y. Y. Fu, Q. Peng, S. Guo, G. Liu, J. Li, H. Yang and G. Chen, J.\nMater. Chem. B, 2013, 1, 5762-5767.\n75. M. Young, D. Willits, M. Uchida and T. Douglas, Annu. Rev. Phytopathol.,\n2008, 46, 361-384.\n76. S. Gupta, M. R. Chatni, A. L. N. Rao, V. I. Vullev, L. V. Wang and B. Anvari,\nNanoscale, 2013, 5, 1772-1776.\n77. F.-F. An, Z.-J. Deng, J. Ye, J.-F. Zhang, Y.-L. Yang, C.-H. Li, C.-J. Zheng and\nX.-H. Zhang, ACS Appl. Mat. Interfaces, 2014, 6, 17985-17992.\n78. D. Zhang, Z.-Y. Qiao, U. Mayerhoeffer, P. Spenst, X. J. Li, F. Würthner and\nH. Wang, Bioconjugate Chem., 2014, 25, 2021-2029.\n79. H.-W. An, S.-L. Qiao, C.-Y. Hou, Y.-X. Lin, L.-L. Li, H.-Y. Xie, Y. Wang, L.\nWang and H. Wang, Chem. Commun., 2015, 51, 13488-13491.\n80. P. Huang, P. Rong, J. Lin, W. Li, X. Yan, M. G. Zhang, Liming Nie, Gang Niu,\nJ. Lu, W. Wang, and X. Chen, J. Am. Chem. Soc., 2014, 136, 8307-8313.\n81. P. Huang, J. Lin, W. Li, P. Rong, Z. Wang, S. Wang, X. Wang, X. Sun, M.\nAronova, G. Niu, R. D. Leapman, Z. Nie, and X. Chen, Angew. Chem. Int. Ed., 2013, 52, 13958-13964. 82. J. Lin, S. Wang, P. Huang, Z. Wang, S. Chen, G. Niu, W. Li, J. He, D. Cui, G.\nLu, X. Chen, and Z. Nie, ACS Nano, 2013, 7, 5320-5329.\n83. Y. Zhang, M. Jeon, L. J. Rich, H. Hong, J. Geng, Y. Zhang, S. Shi, T. E.\nBarnhart, P. Alexandridis, J. D. Huizinga, M. Seshadri, W. Cai, C. Kim and J. F. Lovell, Nat. Nanotech., 2014, 9, 631-638. 84. S. Sreejith, J. Joseph, M. Lin, N. V. Menon, P. Borah, H. J. Ng, Y. X. Loong,\nY. Kang, S. W.-K. Yu and Y. Zhao, ACS Nano, 2015, 9, 5695-5704.\n85. C. E. Callmann, C. V. Barback, M. P. Thompson, D. J. Hall, R. F. Mattrey\nand N. C. Gianneschi, Adv. Mater., 2015, 27, 4611-4615.\n86. M.-P. Chien, A. S. Carlini, D. Hu, C. V. Barback, A. M. Rush, D. J. Hall, G.\nOrr and N. C. Gianneschi, J. Am. Chem. Soc., 2013, 135, 18710-18713.\n87. T. J. Moyer, J. A. Finbloom, F. Chen, D. J. Toft, V. L. Cryns and S. I. Stupp,\nJ. Am. Chem. Soc., 2014, 136, 14746-14752.\n88. C. J. Newcomb, S. Sur, J. H. Ortony, O.-S. Lee, J. B. Matson, J. Boekhoven,\nJ. M. Yu, G. C. Schatz and S. I. Stupp, Nat. Commun., 2014, 5, 3321.\n89. D. Yuan, J. Shi, X. Du, N. Zhou and B. Xu, J. Am. Chem. Soc., 2015, 137,\n10092-10095.\n90. Z. Duan, Y.-J. Gao, Z.-Y. Qiao, S. Qiao, Y. Wang, C. Hou, L. Wang and H.\nWang, Nanotechnology, 2015, 26, 355703.\n91. A. Dragulescu-Andrasi, S.-R. Kothapalli, G. A. Tikhomirov, J. Rao and S. S.\nGambhir, J. Am. Chem. Soc., 2013, 135, 11015-11022.\n92. D. Zhang, G.-B. Qi, Y.-X. Zhao, S.-L. Qiao, C. Yang and H. Wang, Adv.\nMater., 2015, DOI: 10.1002/adma.201502598.\n93. L.-L. Li, H.-L. Ma, G.-B. Qi, D. Zhang, F. Yu, Z. Hu and H. Wang, Adv.\nMater., 2015, DOI: 10.1002/adma.201503437.\n94. Z. Duan, Y.-J. Gao, Z.-Y. Qiao, G. Fan, Y. Liu, D. Zhang and H. Wang, J.\nMater. Chem. B, 2014, 2, 6271-6282.\n95. E. Huynh, Y. C. LeungBen, B. L. Helfield, M. Shakiba, J.-A. Gandier, C. S.\nJin, E. R. Master, B. C. Wilson, D. E. Goertz and G. Zheng, Nat. Nanotech., 2015, 10, 325-332.\nPage 10 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n1 / 22\nSelf-assembled nanomaterials for photoacoustic imaging\nLei Wang* Pei-Pei Yang, Xiao-Xiao Zhao and Hao Wang*"
    }, {
      "heading" : "CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for",
      "text" : ""
    }, {
      "heading" : "Nanoscience and Technology, No. 11 Beiyitiao, Zhongguancun, Haidian District , Beijing, 100190, China",
      "text" : "Email: wanghao@nanoctr.cn and wanglei@nanoctr.cn\nPage 11 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n2 / 22\nTable 1. PA imaging system (MSOT) performance versus other imaging modalities. 47\nBiomedical Imaging\nPlatform\nImaging Quality Parameters\nSpatial\nResolution Sensitivity\nReal-Time\nImaging\nThroughput\nCapacity\nPenetration\nDepth\nUS ~30-50 µm 10 -8 M Y High Medium CT ~10-50 µm 10 -6 M N High High\nMRI ~100 µm 10 -9 M N Low High PET ~1 mm 10 -15 M N Low High\nSPECT ~0.5 mm 10 -14 M N Low High\nOptical ~1 mm 10 -12 M Y High Low\nMOST ~50 µm 10 -12 M Y High Medium\nPage 12 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n3 / 22\nFigure 1. Different classes of self-assembled nanomaterials for PA imaging.\nPage 13 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n4 / 22\nFigure 2. The molecular structures of organic dyes with NIR absorbance used in nanomaterials.\nPage 14 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n5 / 22\nFigure 3. (a) The structure illumination and (b) TEM imaging of 3% ICG loaded-HSA-PAA NPs. (Reproduced with permission. 55 Copyright 2013, Royal Society of Chemistry)\nPage 15 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\nPage 16 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n7 / 22\nFigure 5. (a) Chemical structures of PPy. (b) Schematic illustration of the formation of PPy NPs in an aqueous dispersion of water-soluble polymer–metal cation complexes. (c) Chemical structures of the\nPFTTQ polymer. (d) Schematic illustration of the fabrication of PFTTQ NPs using DSPE-PEG2000 for stabilization through a precipitation method. (a, b: Reproduced with permission. 67 Copyright 2013, Royal Society of Chemistry; c-d: Reproduced with permission. 70 Copyright 2014, Royal Society of\nChemistry)\nPage 17 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\nFigure 6. (a) Dye-loaded SWNT with RGD targeting groups. The dye is attached to the SWNT surface through noncovalent π-π stacking. (b) Optical spectra of SWNT-QSY (red) and SWNT-ICG (green). (c) PA vertical slice image through an agarose phantom containing increasing number of U87 cancer cells\nexposed to SWNT-ICG-RGD and plain SWNT-RGD particles. The signal inside the ROI (dotted white boxes) is not homogenous due to possible aggregates of cells. (a, b: Reproduced with permission. 71 Copyright 2012, American Chemical Society; c: Reproduced with permission. 72 Copyright 2010,\nAmerican Chemical Society)\nPage 18 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n9 / 22\nFigure 7. (a) π–π stacking of dyes in close proximity to GO. GO quenches the dye fluorescence via FRET between dye molecules and GO. Using the pulse laser irradiation, the vast majority of absorbed light energy is converted to acoustic waves. The comparison of PA imaging contrast of tumors after\nbeing injected with GO–Abs/Cy7, GO–Abs, and Cy7. U87-bearing Balb/c nude mice (n = 3) was injected\nthrough the tail vein with GO–Abs/Cy7 (b), and separate GO-Abs and Cy7 solutions were injected\nsimultaneously into the same mice (c). The white dotted lines on the images illustrate the approximate tumor edges. (Reproduced with permission. 73 Copyright 2015, Wiley Publishing Group)\nPage 19 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\nFigure 8. (a) Schematic of dye-loaded PFC nanoparticles. The PFC core is encapsulated in an\namphiphilic phospholipid layer (blue) containing hydrophobic dyes (green). (b) Bright-field and PA\nimages of ex vivo lymph nodes 24 h after intradermal administration of PPCy-C8/PFC nanoparticles\ninto the left forepaw of the rat. (c) Schematic of trimodal MBs. (d) In vivo imaging of MBs in a KB\ntumor xenograft at 10-30 s post intravenous injection of 280 μL of MB-PBS solution at a concentration of 2 × 10 9 MBs/mL. (a, b: Reproduced with permission. 60 Copyright 2011, American Chemical Society); c, d: Reproduced with permission. 59 Copyright 2014, American Chemical Society)\nPage 20 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n11 / 22\nFigure 9. Schematic diagram of the nanoconfined SQ assemblies in phospholipid bilayer and the\nutilization of these vesicles as probes for dual modular tumor imaging in vivo. (Reproduced with permission. 78 Copyright 2014, American Chemical Society)\nPage 21 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n12 / 22\nFigure 10. (a) TEM images of SQ ⊂ L. (b) UV-vis absorption spectra and the corresponding fluorescence intensity changes (inset, λex: 680 nm) of aggregated SQ (4 μM) in PBS and SQ monomers (4 μM) in SQ ⊂ L. (c) PA signal was enhanced with increasing ratio of SQ and phospholipid in liposomes from 1:500 to 1:10 (w/w). (d) PA imaging of tumor in MCF-7 xenografted mice: (I) and (II) are the representative photos of tumor bearing mice with different treatments; (III) and (IV) show one transverse slice in the 3D PA image of tumor bearing mice with treatment of liposome and SQ ⊂ L. The dashed line and the white dashed circle indicate the skin and outlines of tumor site of mice, respectively; (V) and (VI) show the aligned images from the different transverse section of control and\ntreated groups. 78 Copyright 2014, American Chemical Society)\nPage 22 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n13 / 22\nFigure 11. (a) The molecular structure and schematic representation of a pyropheophorbide-lipid porphysomes and enzymatic degradation of the porphysomes. The phospholipid headgroup (red) and\nporphyrin (blue) are highlighted in the subunit. (b) TEM of porphysomes (5% PEG–lipid, 95%\npyropheophorbide–lipid). (c) PA images of tubing containing porphysomes and PBS measured 0.5%\nTriton X-100. (d) The PA lymphatic mapping. Rats were imaged using PA tomography before and after\nintradermal injection of porphysomes (2.3 pmol). Secondary lymph vessels (cyan), lymph node (red), inflowing lymph vessel (yellow) and 5 mm scale bar are indicated. (Reproduced with permission. 57\nCopyright 2011, Nature)\nPage 23 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\nPage 24 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\nPage 25 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\nPage 26 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n17 / 22\nFigure 15. Schematic illustration of activatable oligomerization-induced construction of nanoassemblies in situ for PA imaging of furin-like activity in vivo. (Reproduced with permission. 91 Copyright 2012, American Chemical Society)\nPage 27 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n18 / 22\nFigure 16. Schematic illustration of the structure of P18-1 and it responsively self-assembled into nanofibers in tumor sites that exhibited AIR effect for improving PA imaging signal and tumor\ntherapeutic efficacy. (Reproduced with permission. 92 Copyright 2015, Wiley Publishing Group)\nPage 28 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n19 / 22\nFigure 17. (a) In situ quantification of PA signal intensity in tumor site with time increase from 0.5 to 24 h post-injection. (b) TEM image (inset) of nanofibers formed in tumor site at 10 h-post intravenous injection of compound 1 and the corresponding the energy-dispersive profiles acquired at the region of interests (ROIs) indicated by red stars. (c) The schematic illustration of the AIR effect of compound 1 in tumor site compared with compound 2 which was quickly excreted from the tumor. (Reproduced\nwith permission. 92 Copyright 2015, Wiley Publishing Group)\nPage 29 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n20 / 22\nFigure 18. (a) Illustration of bacterial infection imaging based on an in vivo aggregation strategy. Firstly, the targeting molecule (Van) causes Ppa-PLGVRG-Van to accumulate at the site of responsive bacterial myositis; then, the gelatinase produced by gelatinase-positive bacteria in the infectious\nmicroenvironment cleaves the peptide linker, triggering self-aggregation in situ; finally, the\nsupramolecular aggregates significantly enhance the photoacoustic signal so that the bacterial\ninfection can be detected by imaging. (b) PA images and PA signal intensity distribution in transverse sections of mice up to 72 h after injection with 1. (Reproduced with permission. 93 Copyright 2015,\nWiley Publishing Group)\nPage 30 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n21 / 22\nFigure 19. Schematics of porphyrin microbubbles (pMBs) and their micro-to-nano conversion. (a)\nMolecular structure of BChl-lipid. (b) Self-assembled pMBs consist of a BChl-lipid shell encapsulating\nperfluorocarbon gas. (c) Porphyrin nanoparticles (pNPs) converted from pMBs via sonication with low-frequency, high-duty-cycle ultrasound (conversion ultrasound). (Reproduced with permission. 95\nCopyright 2015, Nature)\nPage 31 of 32 Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A\n22 / 22\nFigure 20. (a) Light microscopy image of pMBs. (b) TEM image of pNPs formed from pMBs after ten ultrasound pulses. (c) TEM image of liposome-like structures formed from pNPs after placing pNPs in a vacuum. (d) Normalized PA signal over time in the tumor, with conversion ultrasound not applied (blue) or applied (green). PA values are normalized to the peak PA value. Mean ± 1 s.d. (n = 3). Only in\ntumors in which conversion ultrasound was applied does the pNP remain at the tumors site, indicating successful delivery to the tumor. (Reproduced with permission. 95 Copyright 2015, Nature)\nPage 32 of 32Nanoscale\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n2 2\nD ec\nem be\nr 20\n15 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa n\nD ie\ngo o\nn 06\n/0 1/\n20 16\n1 4:\n42 :0\n2.\nView Article Online DOI: 10.1039/C5NR07437A"
    } ],
    "references" : [ {
      "title" : "Angew",
      "author" : [ "J.M. Lehn" ],
      "venue" : "Chem. Int. Ed.,",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 1988
    }, {
      "title" : "and S",
      "author" : [ "T. Aida", "E.W. Meije" ],
      "venue" : "I. Stupp, Science,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Adv",
      "author" : [ "L. Wang", "L.-L. Li", "Y.-S. Fan", "H. Wang" ],
      "venue" : "Mater.,",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and G",
      "author" : [ "E. Huyn" ],
      "venue" : "Zheng, Nano Today,",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "T.F.A. De Greef", "M.M.J. Smulders", "M. Wolffs", "A. Schenning", "R.P. Sijbesma", "E.W. Meijer" ],
      "venue" : "Rev.,",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Acc",
      "author" : [ "H. Yang", "B. Yuan", "X. Zhang", "O.A. Scherman" ],
      "venue" : "Chem. Res.,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "X. Yan", "T.R. Cook", "P. Wang", "F. Huang", "P.J. Stang" ],
      "venue" : "Chem.,",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "W. He", "G. Pan", "Z. Yang", "D. Zhao", "G. Niu", "W. Huang", "X. Yuan", "J. Guo", "H. Cao", "H. Yang" ],
      "venue" : "Mater.,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Coord",
      "author" : [ "H. Zhang", "R. Zou", "Y. Zhao" ],
      "venue" : "Chem. Rev.,",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and Y",
      "author" : [ "C.A. Yang", "J.P.K. Tan", "W. Cheng", "A.B.E. Attia", "C.T.Y. Ting", "A. Nelson", "J.L. Hedric" ],
      "venue" : "Y. Yang, Nano Today,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Acc",
      "author" : [ "M.W. Ambrogio", "C.R. Thomas", "Y.L. Zhao", "J.I. Zink", "J.F. Stoddartt" ],
      "venue" : "Chem. Res.,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chin",
      "author" : [ "J. Zhang", "Z. Qiao", "P. Yang", "J. Pan", "L. Wang", "H. Wang" ],
      "venue" : "J. Chem.,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "J. Boekhoven", "S.I. Stupp" ],
      "venue" : "Mater.,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and Y",
      "author" : [ "Z. Wu", "N. Song", "R. Menz", "B. Pingali", "Y.-W. Yan" ],
      "venue" : "Zheng, Nanomedicine,",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "C. Zhao", "X. Zhang", "K. Li", "S. Zhu", "Z. Guo", "L. Zhang", "F. Wang", "Q. Fei", "S. Luo", "P. Shi", "H. Tian", "W.-H. Zhu", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "S.S. Agasti", "S. Rana", "M.H. Park", "C.K. Kim", "C.C. You", "V.M. Rotello" ],
      "venue" : "Drug Del. Rev.,",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Angew",
      "author" : [ "H. Wang", "S.T. Wang", "H. Su", "K.J. Chen", "A.L. Armijo", "W.Y. Lin", "Y.J. Wang", "J. Sun", "K. Kamei", "J. Czernin", "C.G. Radu", "H.R. Tseng" ],
      "venue" : "Chem. Int. Ed.,",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Angew",
      "author" : [ "S. Wang", "K.-J. Chen", "T.-H. Wu", "H. Wang", "W.-Y. Lin", "M. Ohashi", "P.-Y. Chiou", "H.-R. Tseng" ],
      "venue" : "Chem. Int. Ed.,",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Chin",
      "author" : [ "P. Yang", "L. Wang", "H. Wang" ],
      "venue" : "J. Chem.,",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Acc",
      "author" : [ "D.-S. Guo", "Y. Liu" ],
      "venue" : "Chem. Res.,",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and B",
      "author" : [ "Y. Gao", "C. Berciu", "Y. Kuang", "J.F. Shi", "D. Nicastr" ],
      "venue" : "Xu, ACS Nano,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Nat",
      "author" : [ "Y. Gao", "J.F. Shi", "D. Yuan", "B. Xu" ],
      "venue" : "Commun., 2012, 3,",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 1033
    }, {
      "title" : "Chem",
      "author" : [ "J. Zhou", "X. Du", "J. Li", "N. Yamagata", "B. Xu", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nat",
      "author" : [ "G.L. Liang", "H.J. Ren", "J.H. Rao" ],
      "venue" : "Chem.,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Chem",
      "author" : [ "A. Dragulescu-Andrasi", "S.R. Kothapalli", "G.A. Tikhomirov", "J. Rao", "S.S. Gambhir", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Sci",
      "author" : [ "C.Y. Cao", "Y.Y. Shen", "J.D. Wang", "L. Li", "G.L. Liang" ],
      "venue" : "Rep.,",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Nat",
      "author" : [ "D.J. Ye", "A.J. Shuhendler", "L.N. Cui", "L. Tong", "S.S. Tee", "G. Tikhomirov", "D.W. Felsher", "J.H. Rao" ],
      "venue" : "Chem.,",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and H",
      "author" : [ "H. Nejadnik", "D. Ye", "O.D. Lenkov", "J.S. Donig", "J.E. Martin", "R. Castillo", "N. Derugin", "B. Sennino", "J. Ra" ],
      "venue" : "Daldrup-Link, ACS Nano,",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "Q.Q. Miao", "X.Y. Bai", "Y.Y. Shen", "B. Mei", "J.H. Gao", "L. Li", "G.L. Liang" ],
      "venue" : "Commun.,",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "J. Liang", "B.Z. Tang", "B. Liu" ],
      "venue" : "Soc. Rev.,",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "R.T.K. Kwok", "C.W.T. Leung", "J.W.Y. Lam", "B.Z. Tang" ],
      "venue" : "Soc. Rev.,",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "H.B. Shi", "R.T.K. Kwok", "J.Z. Liu", "B.G. Xing", "B.Z. Tang", "B. Liu", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "J. Shi", "X. Du", "Y. Huang", "J. Zhou", "D. Yuan", "D. Wu", "Y. Zhang", "R. Haburcak", "I.R. Epstein", "B. Xu", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Acc",
      "author" : [ "Z. Yang", "G. Liang", "B. Xu" ],
      "venue" : "Chem. Res.,",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Chin",
      "author" : [ "L. Wang", "L.-L. Li", "H.L. Ma", "H. Wang" ],
      "venue" : "Chem. Lett.,",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "A. Dima", "N.C. Burton", "V. Ntziachristos" ],
      "venue" : "Biomed. Opt.,",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Annu",
      "author" : [ "L.V. Wang", "L. Gao" ],
      "venue" : "Rev. Biomed. Eng.,",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Rev",
      "author" : [ "M. Xu", "L.V. Wang" ],
      "venue" : "Sci. Instrum.,",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Adv",
      "author" : [ "C. Wang", "X. Ma", "S. Ye", "L. Cheng", "K. Yang", "L. Guo", "C. Li", "Y. Li", "Z. Liu" ],
      "venue" : "Funct. Mater.,",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Biomed",
      "author" : [ "T. Wang", "Y. Yang", "U. Alqasemi", "P.D. Kumavor", "X. Wang", "M. Sanders", "M. Brewer", "Q. Zhu" ],
      "venue" : "Opt. Express,",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "X. Wang", "X. Xie", "G. Ku", "L.V. Wang", "G. Stoica" ],
      "venue" : "Biomed. Opt.,",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Proc",
      "author" : [ "L. Meng-Lin", "O. Jung-Taek", "X. Xie", "G. Ku", "W. Wei", "L. Chun", "G. Lungu", "G. Stoica", "L.V. Wang" ],
      "venue" : "IEEE,",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Sci",
      "author" : [ "C.J.H. Ho", "G. Balasundaram", "W. Driessen", "R. McLaren", "C.L. Wong", "U.S. Dinish", "A.B.E. Attia", "V. Ntziachristos", "M. Olivo" ],
      "venue" : "Rep.,",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "X. Wang", "Y. Pang", "G. Ku", "X. Xie", "G. Stoica", "L.V. Wang" ],
      "venue" : "Biotechnol.,",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "and S",
      "author" : [ "L.V. Wan" ],
      "venue" : "Hu, Science,",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "J",
      "author" : [ "A. Taruttis", "J. Claussen", "D. Razansky", "V. Ntziachristos" ],
      "venue" : "Biomed. Opt.,",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "V. Ntziachristos", "D. Razansky" ],
      "venue" : "Rev.,",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Chem",
      "author" : [ "L. Nie", "X. Chen" ],
      "venue" : "Soc. Rev.,",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and C",
      "author" : [ "K. Liu", "H. Wang", "K.J. Chen", "F. Guo", "W.Y. Lin", "Y.C. Chen", "D.L. Phung", "H.R. Tsen" ],
      "venue" : "K. F. Shen, Nanotechnology,",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and H",
      "author" : [ "F.P. Gao", "Y.X. Lin", "L.L. Li", "Y. Liu", "U. Mayerhöffer", "P. Spenst", "J.G. Su", "J.Y. Li", "F. Würthne" ],
      "venue" : "Wang, Biomaterials,",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and Z",
      "author" : [ "H.M. Wang", "J. Wei", "C.B. Yang", "H.Y. Zhao", "D.X. Li", "Z.N. Yi" ],
      "venue" : "M. Yang, Biomaterials,",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and G",
      "author" : [ "Y. Che" ],
      "venue" : "L. Liang, Theranostics,",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "Y. Jiao", "K. Liu", "G. Wang", "Y. Wang", "X. Zhang" ],
      "venue" : "Sci.,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "H.K. Yoon", "A. Ray", "Y.-E.K. Lee", "G. Kim", "X. Wang", "R. Kopelman", "J. Mater" ],
      "venue" : "B,",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "H. Gong", "Z. Dong", "Y. Liu", "S. Yin", "L. Cheng", "W. Xi", "J. Xiang", "K. Liu", "Y. Li", "Z. Liu" ],
      "venue" : "Funct. Mater.,",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "J.F. Lovell", "C.S. Jin", "E. Huynh", "H. Jin", "C. Kim", "J.L. Rubinstein", "W.C.W. Chan", "W. Cao", "L.V. Wang", "G. Zheng" ],
      "venue" : "Mater.,",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chem",
      "author" : [ "E. Huynh", "J.F. Lovell", "B.L. Helfield", "M. Jeon", "C. Kim", "D.E. Goertz", "B.C. Wilson", "G. Zheng", "J. Am" ],
      "venue" : "Soc., 2012, 134, 16464-16467.  Page 9 of 32  Nanoscale N  an  os  ca  le  A  cc  ep  te  d  M  an  us  cr  ip t Pu  bl  is  he  d  on  2  2  D  ec  em  be  r  20  15  .  D  ow  nl  oa  de  d  by  U  ni  ve  rs  ity  o  f  C  al  if  or  ni  a   Sa  n  D  ie  go  o  n  06  /0  1/  20  16  1  4:  42  :0 2.  View Article Online DOI: 10.1039/C5NR07437A  ARTICLE Journal Name 10 | J. Name.,",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and G",
      "author" : [ "E. Huynh", "C.S. Jin", "B.C. Wilso" ],
      "venue" : "Zheng, Bioconjugate Chem.,",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and S",
      "author" : [ "W.J. Akers", "C. Kim", "M. Berezin", "K. Guo", "R. Fuhrhop", "G.M. Lanza", "G.M. Fischer", "E. Daltrozzo", "A. Zumbusch", "X. Cai", "L.V. Wan" ],
      "venue" : "Achilefu, ACS Nano,",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Chem",
      "author" : [ "M. Frenette", "M. Hatamimoslehabadi", "S. Bellinger-Buckley", "S. Laoui", "J. La", "S. Bag", "S. Mallidi", "T. Hasan", "B. Bouma", "C. Yeleswarapu", "J. Rochford", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "K. Li", "B. Liu" ],
      "venue" : "Soc. Rev.,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and R",
      "author" : [ "Y. Kohl", "C. Kaiser", "W. Bost", "F. Stracke", "M. Fournelle", "C. Wischke", "H. Thielecke", "A. Lendlein", "K. Krat" ],
      "venue" : "Lemor, Nanomedicine,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and Z",
      "author" : [ "X. Song", "R. Zhang", "C. Liang", "Q. Chen", "H. Gon" ],
      "venue" : "Liu, Biomaterials,",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nat",
      "author" : [ "K. Pu", "A.J. Shuhendler", "J.V. Jokerst", "J. Mei", "S.S. Gambhir", "Z. Bao", "J. Rao" ],
      "venue" : "Nanotech.,",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "K. Pu", "J. Mei", "J.V. Jokerst", "G. Hong", "A.L. Antaris", "N. Chattopadhyay", "A.J. Shuhendler", "T. Kurosawa", "Y. Zhou", "S.S. Gambhir", "Z. Bao", "J. Rao" ],
      "venue" : "Mater.,",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "E",
      "author" : [ "Z. Zha", "Z. Deng", "Y. Li", "C. Li", "J. Wang", "S. Wang" ],
      "venue" : "Qu and Z. Dai, Nanoscale,",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "X. Song", "H. Gong", "S. Yin", "L. Cheng", "C. Wang", "Z. Li", "Y. Li", "X. Wang", "G. Liu", "Z. Liu" ],
      "venue" : "Funct. Mater.,",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Int",
      "author" : [ "G. Balasundaram", "C.J.H. Ho", "K. Li", "W. Driessen", "U.S. Dinish", "C.L. Wong", "V. Ntziachristos", "B. Liu", "M. Olivo" ],
      "venue" : "J. Nanomedicine,",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Poly",
      "author" : [ "J. Liu", "J. Geng", "L.-D. Liao", "N. Thakor", "X. Gao", "B. Liu" ],
      "venue" : "Chem.,",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and D",
      "author" : [ "H. Qin", "T. Zhou", "S. Yan" ],
      "venue" : "Xing, Small,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "Y. Wang", "Y.Y. Fu", "Q. Peng", "S. Guo", "G. Liu", "J. Li", "H. Yang", "G. Chen", "J. Mater" ],
      "venue" : "B,",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Annu",
      "author" : [ "M. Young", "D. Willits", "M. Uchida", "T. Douglas" ],
      "venue" : "Rev. Phytopathol.,",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and B",
      "author" : [ "S. Gupta", "M.R. Chatni", "A.L.N. Rao", "V.I. Vullev", "L.V. Wan" ],
      "venue" : "Anvari, Nanoscale,",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Mat",
      "author" : [ "F.-F. An", "Z.-J. Deng", "J. Ye", "J.-F. Zhang", "Y.-L. Yang", "C.-H. Li", "C.-J. Zheng", "X.-H. Zhang", "ACS Appl" ],
      "venue" : "Interfaces,",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and H",
      "author" : [ "D. Zhang", "Z.-Y. Qiao", "U. Mayerhoeffer", "P. Spenst", "X.J. Li", "F. Würthne" ],
      "venue" : "Wang, Bioconjugate Chem.,",
      "citeRegEx" : "78",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "H.-W. An", "S.-L. Qiao", "C.-Y. Hou", "Y.-X. Lin", "L.-L. Li", "H.-Y. Xie", "Y. Wang", "L. Wang", "H. Wang" ],
      "venue" : "Commun.,",
      "citeRegEx" : "79",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Liming Nie, Gang Niu, J",
      "author" : [ "P. Huang", "P. Rong", "J. Lin", "W. Li", "X. Yan", "M.G. Zhang" ],
      "venue" : "Lu, W. Wang, and X. Chen, J. Am. Chem. Soc.,",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Angew",
      "author" : [ "P. Huang", "J. Lin", "W. Li", "P. Rong", "Z. Wang", "S. Wang", "X. Wang", "X. Sun", "M. Aronova", "G. Niu", "R.D. Leapman", "Z. Nie", "X. Chen" ],
      "venue" : "Chem. Int. Ed.,",
      "citeRegEx" : "81",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and Z",
      "author" : [ "J. Lin", "S. Wang", "P. Huang", "Z. Wang", "S. Chen", "G. Niu", "W. Li", "J. He", "D. Cui", "G. Lu", "X. Chen" ],
      "venue" : "Nie, ACS Nano,",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Nat",
      "author" : [ "Y. Zhang", "M. Jeon", "L.J. Rich", "H. Hong", "J. Geng", "Y. Zhang", "S. Shi", "T.E. Barnhart", "P. Alexandridis", "J.D. Huizinga", "M. Seshadri", "W. Cai", "C. Kim", "J.F. Lovell" ],
      "venue" : "Nanotech.,",
      "citeRegEx" : "83",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "S",
      "author" : [ "S. Sreejith", "J. Joseph", "M. Lin", "N.V. Menon", "P. Borah", "H.J. Ng", "Y.X. Loong", "Y. Kang" ],
      "venue" : "W.-K. Yu and Y. Zhao, ACS Nano,",
      "citeRegEx" : "84",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "C.E. Callmann", "C.V. Barback", "M.P. Thompson", "D.J. Hall", "R.F. Mattrey", "N.C. Gianneschi" ],
      "venue" : "Mater.,",
      "citeRegEx" : "85",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "M.-P. Chien", "A.S. Carlini", "D. Hu", "C.V. Barback", "A.M. Rush", "D.J. Hall", "G. Orr", "N.C. Gianneschi", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "86",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "T.J. Moyer", "J.A. Finbloom", "F. Chen", "D.J. Toft", "V.L. Cryns", "S.I. Stupp", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "87",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Nat",
      "author" : [ "C.J. Newcomb", "S. Sur", "J.H. Ortony", "O.-S. Lee", "J.B. Matson", "J. Boekhoven", "J.M. Yu", "G.C. Schatz", "S.I. Stupp" ],
      "venue" : "Commun.,",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "D. Yuan", "J. Shi", "X. Du", "N. Zhou", "B. Xu", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "89",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and H",
      "author" : [ "Z. Duan", "Y.-J. Gao", "Z.-Y. Qiao", "S. Qiao", "Y. Wang", "C. Hou", "L. Wan" ],
      "venue" : "Wang, Nanotechnology,",
      "citeRegEx" : "90",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "A. Dragulescu-Andrasi", "S.-R. Kothapalli", "G.A. Tikhomirov", "J. Rao", "S.S. Gambhir", "J. Am" ],
      "venue" : "Soc.,",
      "citeRegEx" : "91",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Adv",
      "author" : [ "D. Zhang", "G.-B. Qi", "Y.-X. Zhao", "S.-L. Qiao", "C. Yang", "H. Wang" ],
      "venue" : "Mater.,",
      "citeRegEx" : "92",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Adv",
      "author" : [ "L.-L. Li", "H.-L. Ma", "G.-B. Qi", "D. Zhang", "F. Yu", "Z. Hu", "H. Wang" ],
      "venue" : "Mater.,",
      "citeRegEx" : "93",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "Z. Duan", "Y.-J. Gao", "Z.-Y. Qiao", "G. Fan", "Y. Liu", "D. Zhang", "H. Wang", "J. Mater" ],
      "venue" : "B,",
      "citeRegEx" : "94",
      "shortCiteRegEx" : null,
      "year" : 2014
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "rationally designed a responsive small-molecule precursor (1) that self-assembled into nanofibers in tumor sites exhibiting assembly-induced retention (AIR) effect, and improved PA imaging signal and enhanced therapeutic efficacy (Figure 16).",
      "startOffset" : 58,
      "endOffset" : 61
    } ],
    "year" : 2015,
    "abstractText" : "Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. Accepted Manuscript Nanoscale",
    "creator" : "Aspose Ltd."
  }
}